Ang Healthcare India Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 15-11-2024
- Paid Up Capital ₹ 2.50 Cr
as on 15-11-2024
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.22 Cr
as on 15-11-2024
- Satisfied Charges ₹ 1.00 Cr
as on 15-11-2024
- Revenue 32.64%
(FY 2023)
- Profit 464.71%
(FY 2023)
- Ebitda 190.20%
(FY 2023)
- Net Worth 5.58%
(FY 2023)
- Total Assets 67.44%
(FY 2023)
About Ang Healthcare India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.50 Cr.
The company currently has active open charges totaling ₹5.22 Cr. The company has closed loans amounting to ₹1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Gupta and Neeraj Gupta serve as directors at the Company.
- CIN/LLPIN
U24230HP2016PTC006198
- Company No.
006198
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Apr 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ang Healthcare India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Gupta  | Director | 29-Dec-2023 | Current |
| Neeraj Gupta | Director | 25-Apr-2016 | Current |
Financial Performance and Corporate Structure Insights of Ang Healthcare India.
Ang Healthcare India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 32.64% increase. The company also saw a substantial improvement in profitability, with a 464.71% increase in profit. The company's net worth moved up by a moderate rise of 5.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ang Healthcare India?
In 2023, Ang Healthcare India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 13 Mar 2024 | ₹2.20 M | Open |
Others Creation Date: 07 Nov 2023 | ₹5.00 Cr | Open |
Others Creation Date: 09 May 2016 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Ang Healthcare India?
Ang Healthcare India has a workforce of 189 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ang Healthcare India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ang Healthcare India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
